• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct27
Luoxin Pharmaceutical released FY2025 9 Months Earnings on October 27 (BJT), with actual revenue of CNY 1.723 B and EPS of CNY 0.0035
15:00
Luoxin Pharmaceutical released FY2025 Q3 earnings on October 27 (BJT), actual revenue CNY 646.17 M, actual EPS CNY 0.0035
15:00
Aug27
Luoxin Pharmaceutical released FY2025 Q2 earnings on August 27 (BJT), actual revenue CNY 594.52 M, actual EPS CNY 0.01
15:00
Jul11
Luoxin Pharmaceutical Reports Forecasted Profit for First Half of 2025
08:58
Jun12
Major Shareholder of Luoxin Pharmaceutical Plans to Reduce Shareholding
11:52
Jun9
Chemical Pharmaceutical Sector Continues to Rise
01:49

Schedules & Filings

Schedules
Filings
Oct27
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 646.17 M, Net Income 5.232 M, EPS 0.0035

Aug27
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 594.52 M, Net Income 12.04 M

Apr21
Earning Release(CST)

FY2025 Q1 Earning Release (CNY) Revenue 482.73 M, Net Income 5.651 M

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More